WGS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
GeneDx Holdings Corp (WGS) is not a strong buy at the moment for a beginner investor with a long-term horizon. While the company has promising growth potential and a Buy rating from analysts, the lack of recent positive news, insider selling, and weak financial performance in the latest quarter suggest caution. The technical indicators and options data also do not support a strong bullish case currently.
The MACD is positive and contracting, indicating a mild bullish trend. RSI is neutral at 47.804, and moving averages are converging, showing no clear directional trend. The stock is trading near its pivot level of 65.589, with resistance at 71.766 and support at 59.412. Overall, technical indicators suggest a neutral stance.
Analysts maintain Buy ratings with price targets ranging from $100 to $170, highlighting long-term growth potential. The company is expanding into new markets and has a strong gross margin of 69.65%.
Insider selling has increased significantly by 813.18% in the last month, which could indicate a lack of confidence from insiders. The company's net income and EPS have dropped significantly YoY, and there is no recent positive news or event-driven catalysts. Additionally, hedge funds remain neutral, and there is no recent congress trading data.
In 2025/Q4, revenue increased by 26.50% YoY to $120.99M, but net income dropped by -424.86% YoY to -$17.67M, and EPS fell by -405.00% YoY to -$0.61. Gross margin slightly improved to 69.65%. Overall, the financials show revenue growth but significant profitability challenges.
Analysts maintain a Buy rating with price targets adjusted downward recently. While they see long-term potential, risks such as competition and price elasticity issues are noted. Recent upgrades and positive sentiment from firms like Wells Fargo and Jefferies highlight the company's growth runway but acknowledge a noisy start to 2026.
